ABSTRACTS Archives - Page 47 of 108

PP32 Retrospective real-world data confirms the efficacy and safety of decitabine in treating patients with acute myeloid leukemia in Belgium

BJH - volume 8, issue Abstract Book BHS, february 2017

B. Malfait MD, J. Braakman , L. de Vos , B. Bailly MD, I. Vande Broek MD, PhD, S. Meers MD, D. Dierickx MD, PhD

PP33 Targeted next-generation sequencing using a pan-myeloid panel in myelodysplastic neoplasms: implementation in clinical diagnostics

BJH - volume 8, issue Abstract Book BHS, february 2017

G. Froyen PhD, J. Willemse PhD, A. Broekmans , R. Smets , B. Cruys , N. Put MD, V. Madoe , M. Janssen , O. Soepenberg , G. Bries MD, PhD, B. Maes MD, PhD

PP34 The MLL partial tandem duplication (MLL-PTD) is correlated with WT1 overexpression in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) and shows a similar expression profile during treatment

BJH - volume 8, issue Abstract Book BHS, february 2017

K. Vandepoele PhD, B. Denys MD

PP50 Comparison of xenogeneic graft-versus-host reactions in humanized NSG and NSG-HLA-A2/HHD mice

BJH - volume 8, issue Abstract Book BHS, february 2017

G. Ehx , G. Fransolet , L. Delens , J. Muller MSc, Y. Beguin MD, PhD, S. Humblet-Baron , M. Hannon , prof. F. Baron

PP51 Impact of Th17 cell population on xenogeneic graft-versus-host disease

BJH - volume 8, issue Abstract Book BHS, february 2017

L. Delens

PP52 Daratumumab: Blessing for the patient, but hell for the clinical lab

BJH - volume 8, issue Abstract Book BHS, february 2017

C. van der Heijden , S. Mahieu

PP53 Unexplained anaemia in the Elderly: High prevalence of functional iron deficiency and underdiagnosed myelodysplasia

BJH - volume 8, issue Abstract Book BHS, february 2017

L. Sattar , M. Maerevoet MD, D. Bron MD, PhD, B. Cantinieaux , P. Hermans MD, PhD, T. Pepersack MD, PhD